Risk-Based Care

Tailored care plans for cancer patients that address barriers to treatment and unify the fragmented care system

Risk-Based Care supports patients clinically and emotionally

When patients have personalized care, they’re 35% less likely to end up in the hospital unexpectedly. That’s just one of the reasons why Biologics’ Risk-Based Care approach is so effective.

After an assessment of each patient’s circumstances and challenges, our nurses build a personalized care plan. Then, they work with patients to identify and overcome obstacles to treatment, such as nausea, anxiety or loss of appetite. They maintain regular contact with the patient, updating you and your team as necessary. With risk-based care, the patient is always the priority.

Patient Voice Spotlight: Dan W.

Risk-based care by the numbers


+1.82 months on treatment

Cancer patients with risk-based care plans stayed on therapy for significantly longer periods than patients without care plans—nearly 2 months—and were at lower risk of discontinuing treatment.

Source: Biologics and Arine, 2022

3x less likely to report disease progression

Biologics patients who participated in Risk-Based Care were three times less likely to report disease progression than high‑risk patients who didn’t participate.

Source: Biologics, 2021


35% reduction in reported hospitalizations

The reduction in the rate of reported hospitalizations when patients received personalized support through Risk-Based Care.

Source: Biologics, 2021

Risk-Based Care: Personalized Care for Better Patient Outcomes

Frequently asked questions

Number 1 icon

How do patients sign-up for a personalized care plan?

Our cross functional clinical team identifies high-risk patients receiving specific therapies. To confirm the need for a personalized care plan, a pharmacist first conducts a risk assessment to identify any barriers to treatment before receiving therapy. We pair every patient with a dedicated nurse who will manage their care during therapy. Our Risk-Based Care plan is part of our way of helping patients achieve the best possible outcomes.

Number 2 icon

Do my patients need a personalized care plan to receive their prescription from Biologics?

No, patients do not need a personalized care plan to receive their prescription from Biologics. However, if your high-risk patient qualifies for the risk based care program, they will receive a phone call from a pharmacist to assess their potential barriers to treatment. If a patient does not want a nurse to follow-up, they can opt  out of the program and still receive their prescription.

Number 3 icon

Will a nurse keep me informed of my patient’s progress?

Our Risk-Based Care program closely models the type of care that you receive in face-to-face clinical settings, where patients are supported by familiar providers who know the particulars of their situation. This care model recognizes that patients benefit from continual, consistent, and individualized support at a level that’s appropriate for them throughout the treatment journey. A nurse will only contact a patient’s doctor, if the patient makes this request.

How often will a nurse contact a patient?

The cadence depends on a patient’s personal challenges, clinical needs and the ease, or difficulty, of therapy. Sometimes, the frequency of calls to a single patient change throughout the course of therapy. Supporting each patient with an individualized plan allows nurses to manage care more effectively—the way it’s done in a hospital or clinic setting.


Discover how Biologics by McKesson helps patients stay on therapies longer with risk-based care.

Want to learn more?

We’re here to help—contact us or browse career opportunities.